Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF TOTAL CONSIDERATION ON BUSINESS CONSIDERATION (Details)

v3.22.1
SUMMARY OF TOTAL CONSIDERATION ON BUSINESS CONSIDERATION (Details) - medSR Purchase Price [Member]
$ in Thousands
Jun. 01, 2021
USD ($)
Business Acquisition [Line Items]  
Cash $ 12,261
Amounts held in escrow 1,571
Contingent consideration 5,605
Total purchase price $ 19,437